Cowen

Visteon Announces Ryan Wentling as Vice President of Investor Relations and Treasurer

Retrieved on: 
Tuesday, April 25, 2023

VAN BUREN TOWNSHIP, Mich., April 25, 2023 (GLOBE NEWSWIRE) -- Visteon Corporation (Nasdaq: VC), a global technology company serving the mobility industry, today announced the appointment of Ryan Wentling as Vice President of Investor Relations and Treasurer, effective immediately.

Key Points: 
  • VAN BUREN TOWNSHIP, Mich., April 25, 2023 (GLOBE NEWSWIRE) -- Visteon Corporation (Nasdaq: VC), a global technology company serving the mobility industry, today announced the appointment of Ryan Wentling as Vice President of Investor Relations and Treasurer, effective immediately.
  • He succeeds Kris Doyle, who will transition to Vice President of Operations Finance and FP&A.
  • Prior to Visteon, Wentling served in various roles at Constellium, including Business Unit Controller and Director of Investor Relations.
  • "We are pleased to welcome Ryan to Visteon and look forward to the experience and leadership he will bring to our investor relations and treasury functions," said Jerome Rouquet, Visteon Senior Vice President and CFO.

Oppenheimer Hires Michael Cella As U.S. Head of Consumer

Retrieved on: 
Monday, April 17, 2023

NEW YORK, April 17, 2023 /PRNewswire/ -- Oppenheimer & Co. Inc. (Oppenheimer) — a leading investment bank, wealth manager and a subsidiary of Oppenheimer Holdings (NYSE: OPY) —announced today that Michael Cella joined the firm as U.S. Head of Consumer Investment Banking.

Key Points: 
  • NEW YORK, April 17, 2023 /PRNewswire/ -- Oppenheimer & Co. Inc. (Oppenheimer) — a leading investment bank, wealth manager and a subsidiary of Oppenheimer Holdings (NYSE: OPY) —announced today that Michael Cella joined the firm as U.S. Head of Consumer Investment Banking.
  • Cella will be based out of Oppenheimer's San Francisco office and report to Robert Lowenthal, President of Oppenheimer and Head of Investment Banking.
  • Most recently, Cella served as a Managing Director in the Consumer Investment Banking Group at Cowen, now TD Cowen, a division of TD Securities.
  • "I am excited to join Oppenheimer and lead its highly respected U.S. Consumer Investment Banking team," Cella said.

RadNet, Inc. to Present at the 43rd Annual Cowen & Company Healthcare Conference on Tuesday, March 7th

Retrieved on: 
Monday, March 6, 2023

LOS ANGELES, March 06, 2023 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT ), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network owned and operated outpatient imaging centers, today announced that Mark Stolper, Executive Vice President and Chief Financial Officer and Gregory Sorensen, M.D., CEO and co-founder of DeepHealth (RadNet’s Artificial Intelligence Division), will be presenting at the Cowen & Company Healthcare Conference on Tuesday, March 7, 2023 at 9:50 a.m. Eastern Time (6:50 a.m. Pacific Time).

Key Points: 
  • LOS ANGELES, March 06, 2023 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT ), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network owned and operated outpatient imaging centers, today announced that Mark Stolper, Executive Vice President and Chief Financial Officer and Gregory Sorensen, M.D., CEO and co-founder of DeepHealth (RadNet’s Artificial Intelligence Division), will be presenting at the Cowen & Company Healthcare Conference on Tuesday, March 7, 2023 at 9:50 a.m. Eastern Time (6:50 a.m. Pacific Time).
  • There will be simultaneous and archived webcasts available at https://wsw.com/webcast/cowen132/rdnt/2026416 and www.radnet.com under the “About RadNet'' menu section and “News and Press Releases'' sub-menu of the website.
  • Time: 9:50 a.m. Eastern Time / 6:50 a.m. Pacific Time

Vistagen to Present at Cowen 43rd Annual Health Care Conference

Retrieved on: 
Thursday, March 2, 2023

Vistagen (Nasdaq: VTGN), a late clinical-stage biopharmaceutical company aiming to transform the treatment landscape for individuals living with anxiety, depression and other central nervous system (CNS) disorders, today announced that its Chief Executive Officer, Shawn Singh, will present and host one-on-one meetings at the Cowen 43rd Annual Health Care Conference taking place March 6 – 8, 2023 in Boston, MA.

Key Points: 
  • Vistagen (Nasdaq: VTGN), a late clinical-stage biopharmaceutical company aiming to transform the treatment landscape for individuals living with anxiety, depression and other central nervous system (CNS) disorders, today announced that its Chief Executive Officer, Shawn Singh, will present and host one-on-one meetings at the Cowen 43rd Annual Health Care Conference taking place March 6 – 8, 2023 in Boston, MA.
  • Location: Boston Marriott Copley Place in Boston, MA
    The conference incorporates presentations, fireside chats and innovative panel discussions hosted by members of the Cowen research team that focus on various aspects of the health care industry.
  • Investors interested in arranging a one-on-one meeting during the conference should contact the Cowen 43rd Annual Health Care Conference coordinator.

Alector to Participate in Upcoming Healthcare Conferences

Retrieved on: 
Wednesday, March 1, 2023

SOUTH SAN FRANCISCO, Calif., March 01, 2023 (GLOBE NEWSWIRE) -- Alector, Inc. (Nasdaq: ALEC), a clinical-stage biotechnology company pioneering immuno-neurology, today announced that management will participate in the following upcoming investor conferences:

Key Points: 
  • SOUTH SAN FRANCISCO, Calif., March 01, 2023 (GLOBE NEWSWIRE) -- Alector, Inc. (Nasdaq: ALEC), a clinical-stage biotechnology company pioneering immuno-neurology, today announced that management will participate in the following upcoming investor conferences:
    Cowen 43rd Annual Health Care Conference (Boston, Massachusetts)
    A webcast of each conference presentation will be available on the “Events & Presentations” page within the Investors section of the Alector website at http://investors.alector.com.
  • Replays of the Cowen and Stifel webcasts will be available on the Alector website for 30 and 90 days, respectively, following the presentation dates.

UroGen Pharma to Present at Upcoming Investor Conferences

Retrieved on: 
Wednesday, March 1, 2023

UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced that it will present at the following investor conferences in March:

Key Points: 
  • UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced that it will present at the following investor conferences in March:
    Cowen 43rd Annual Health Care Conference — March 7-9, 2023
    Oppenheimer 33rd Annual Healthcare Conference — March 13-15, 2023
    Webcasts for both the Cowen and Oppenheimer presentations will be available via the Investors section of UroGen’s website, www.urogen.com .
  • A replay of each webcast will be available on the Company’s website for approximately 30 days.

Valneva to Present at the Cowen 43rd Annual Healthcare Conference

Retrieved on: 
Wednesday, March 1, 2023

Saint-Herblain (France), March 1, 2023 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that its senior management will present and participate in 1-on-1 meetings with institutional investors at the Cowen 43rd Annual Healthcare Conference, to take place in-person March 6 - 8, 2023 in Boston, Massachusetts.

Key Points: 
  • Saint-Herblain (France), March 1, 2023 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that its senior management will present and participate in 1-on-1 meetings with institutional investors at the Cowen 43rd Annual Healthcare Conference, to take place in-person March 6 - 8, 2023 in Boston, Massachusetts.
  • The presentation will take place on Tuesday, March 7, 2022, at 10:30am ET and will be accessible live via the following link, https://wsw.com/webcast/cowen132/valn/2015538 .
  • A replay of the webcast will be available following the live event in the “Investors” section of the Valneva website at www.valneva.com .
  • To request a meeting at the event, please contact your representative at Cowen.

Pliant Therapeutics to Participate in Upcoming Investor Events

Retrieved on: 
Wednesday, March 1, 2023

SOUTH SAN FRANCISCO, Calif., March 01, 2023 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX), a clinical stage biotechnology company focused on discovering and developing novel therapeutics for the treatment of fibrosis, today announced senior management’s participation at the following investor events in March:

Key Points: 
  • SOUTH SAN FRANCISCO, Calif., March 01, 2023 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX), a clinical stage biotechnology company focused on discovering and developing novel therapeutics for the treatment of fibrosis, today announced senior management’s participation at the following investor events in March:
    Cowen 43rd Annual Health Care Conference Bernard Coulie, M.D., Ph.D., Pliant’s President and Chief Executive Officer, and Éric Lefebvre, M.D., Pliant’s Chief Medical Officer, will participate in a fireside chat on Wednesday, March 8, 2023, at 1:30 p.m.
  • Oppenheimer 33rd Annual Healthcare Conference Bernard Coulie, M.D., Ph.D., Pliant’s President and Chief Executive Officer, and Éric Lefebvre, M.D., Pliant’s Chief Medical Officer, will participate in a virtual fireside chat on Monday, March 13, 2023, at 2:40 p.m.
  • Citi West Coast Biotech Bus Trip Members of Pliant’s senior management will meet with investors on Thursday, March 23, 2023, as part of an invitation-only event hosted by Citi.
  • Interested parties can access the Cowen and Oppenheimer fireside chats from the Investor Relations’ Events & Presentation page of Pliant’s website with an audio archive available for 30 days from the time it is made available.

MDxHealth to Participate in 43rd Annual Cowen Healthcare Conference

Retrieved on: 
Tuesday, February 28, 2023

IRVINE, CA, and HERSTAL, BELGIUM – February 28, 2023 – MDxHealth SA (Nasdaq and Euronext Brussels: MDXH), a commercial-stage precision diagnostics company, today announced that Michael McGarrity, chief executive officer, will present at Cowen’s 43rd Annual Health Care Conference on Monday, March 6th, 2023 at 1:30pm ET.

Key Points: 
  • IRVINE, CA, and HERSTAL, BELGIUM – February 28, 2023 – MDxHealth SA (Nasdaq and Euronext Brussels: MDXH), a commercial-stage precision diagnostics company, today announced that Michael McGarrity, chief executive officer, will present at Cowen’s 43rd Annual Health Care Conference on Monday, March 6th, 2023 at 1:30pm ET.
  • A live webcast of the presentation will be available on the Company’s website.
  • Cowen’s 43rd Annual Health Care Conference is taking place March 6 - 8, 2023, at the Boston Marriott Copley Place in Boston, MA.
  • The conference incorporates presentations, fireside chats and innovative panel discussions hosted by members of the Cowen research team that focus on various aspects of the healthcare industry.

Quanterix to Present at Cowen’s 43rd Annual Health Care Conference

Retrieved on: 
Tuesday, February 28, 2023

Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced that Chief Executive Officer Masoud Toloue will present at Cowen’s 43rd Annual Health Care Conference.

Key Points: 
  • Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced that Chief Executive Officer Masoud Toloue will present at Cowen’s 43rd Annual Health Care Conference.
  • In addition to the session, Quanterix will also host one-on-one meetings with institutional investors during the conference.
  • Cowen’s 43rd Annual Health Care Conference will take place March 6 - 8, 2023, at the Boston Marriott Copley Place in Boston, MA.
  • The conference incorporates presentations, fireside chats and panel discussions hosted by members of the Cowen research team that focus on various aspects of the health care industry.